Bill Commons

ME LD 1772

enacted

An Act To Implement The Recommendations Of The Blue Ribbon Commission To Design A Plan For Sustained Investment In Preventing Disease And Improving The Health Of Maine Communities

Maine · 132 · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did ME LD 1772 pass?

Yes. ME LD 1772 has been enacted into law. Latest recorded action (2026-04-06): Signed by Governor

What is ME LD 1772 about?

ME LD 1772 is a bill in the 132 titled “An Act To Implement The Recommendations Of The Blue Ribbon Commission To Design A Plan For Sustained Investment In Preventing Disease And Improving The Health Of Maine Communities”.

Who sponsors ME LD 1772?

Richard BENNETT is the primary sponsor of ME LD 1772, joined by 3 cosponsors.

Introduced
—
Latest action
2026-04-06 — Signed by Governor
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Richard BENNETTprimary
  • Margaret ROTUNDOcosponsor
  • Anne GRAHAMcosponsor
  • John DUCHARMEcosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-04-06

    Signed by Governor

    executive-signature

  2. 2026-03-25

    PASSED TO BE ENACTED - Emergency - 2/3 Elected Required, in concurrence.

    passage

  3. 2026-03-24

    Sent for concurrence. ORDERED SENT FORTHWITH.

  4. 2026-03-24

    PASSED TO BE ENACTED.

    passage

  5. 2026-03-24

    This being an emergency measure, a two-thirds vote of all the members elected to the House was necessary.

  6. 2026-03-19

    In concurrence. ORDERED SENT FORTHWITH.

  7. 2026-03-19

    The Bill was PASSED TO BE ENGROSSED as Amended by Committee Amendment "A" (S-548).

    reading-3

  8. 2026-03-19

    Under suspension of the rules CONSENT CALENDAR - SECOND DAY.

  9. 2026-03-19

    CONSENT CALENDAR - FIRST DAY

  10. 2026-03-18

    Ordered sent down forthwith for concurrence.

  11. 2026-03-18

    READ A SECOND TIME and PASSED TO BE ENGROSSED AS AMENDED BY Committee Amendment "A" (S-548)

    reading-2,reading-3

  12. 2026-03-18

    COMMITTEE ON BILLS IN THE SECOND READING REPORTS NO FURTHER VERBAL AMENDMENTS NECESSARY. REPORT ACCEPTED.

  13. 2026-03-17

    ASSIGNED FOR SECOND READING NEXT LEGISLATIVE DAY.

  14. 2026-03-17

    Committee Amendment "A" (S-548) READ and ADOPTED.

    committee-passage-favorable

  15. 2026-03-17

    Bill READ ONCE.

    reading-1

  16. 2026-03-17

    Report READ and ACCEPTED.

  17. 2026-03-13

    Reported Out - OTP-AM

  18. 2026-01-21

    Voted - OTP-AM

  19. 2026-01-21

    Work Session Held

  20. 2025-06-25

    CARRIED OVER, in the same posture, to any special or regular session of the 132nd Legislature, pursuant to Joint Order SP 800.

  21. 2025-05-19

    Carry Over Approved

  22. 2025-05-16

    Carry Over Requested

  23. 2025-05-15

    Work Session Held - TABLED

  24. 2025-04-24

    In concurrence. ORDERED SENT FORTHWITH.

  25. 2025-04-24

    The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES.

    referral-committee

  26. 2025-04-24

    Committee on HEALTH AND HUMAN SERVICES suggested and ordered printed REFERENCE to the Committee on HEALTH AND HUMAN SERVICES Ordered sent down forthwith for concurrence

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-10-21T09:13:35.588263Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=ME&identifier=LD 1772. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.